These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15007152)

  • 21. Overactive bladder in patients with myasthenia gravis-A cross-sectional population-based study.
    Donskov AO; Vinge L; Axelsen SM; Andersen H
    Acta Neurol Scand; 2021 Jul; 144(1):76-80. PubMed ID: 33772766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma.
    Gajra A; Vajpayee N; Grethlein SJ
    Am J Hematol; 2004 Oct; 77(2):196-7. PubMed ID: 15389902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of myasthenia gravis with pyridostigmine.
    Grogan WA
    Arch Neurol; 1987 Oct; 44(10):995-6. PubMed ID: 3632385
    [No Abstract]   [Full Text] [Related]  

  • 24. Diseases of the central nervous system. Myasthenia gravis.
    Havard CW
    Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
    [No Abstract]   [Full Text] [Related]  

  • 25. Parkinsonism induced by pyridostigmine.
    Iwasaki Y; Wakata N; Kinoshita M
    Acta Neurol Scand; 1988 Sep; 78(3):236. PubMed ID: 3227809
    [No Abstract]   [Full Text] [Related]  

  • 26. Anticholinesterase abuse in myasthenia gravis.
    Munsat TL
    J Neurol Sci; 1984 Apr; 64(1):5-10. PubMed ID: 6376715
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of myasthenia gravis during pregnancy.
    Bansal R; Goyal MK; Modi M
    Indian J Pharmacol; 2018; 50(6):302-308. PubMed ID: 30783322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myasthenia gravis: a real emergency.
    Kutzin JM
    Int Emerg Nurs; 2012 Apr; 20(2):102-5. PubMed ID: 22483007
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of myasthenia--I.
    Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholinesterase inhibitors in myasthenia gravis.
    Lange MJ
    Practitioner; 1966 Mar; 196(173):448-53. PubMed ID: 5905423
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current treatment of myasthenia gravis].
    de Assis JL
    Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
    [No Abstract]   [Full Text] [Related]  

  • 32. Myasthenia gravis and glycopyrrolate.
    Marcus E; Wayne F
    S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
    [No Abstract]   [Full Text] [Related]  

  • 33. Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis.
    Punga AR; Sawada M; Stålberg EV
    Muscle Nerve; 2008 Mar; 37(3):300-7. PubMed ID: 18069667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.
    Gehi A; Benatar M; Langberg J
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):214-6. PubMed ID: 17711430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic alopecia caused by pyridostigmine bromide.
    Field LM
    Arch Dermatol; 1980 Oct; 116(10):1103. PubMed ID: 7425657
    [No Abstract]   [Full Text] [Related]  

  • 36. Prescription profile of pyridostigmine use in a population of patients with myasthenia gravis.
    Machado-Alba JE; Calvo-Torres LF; Gaviria-Mendoza A; Augusto MejíA-Vélez C
    Muscle Nerve; 2017 Dec; 56(6):1041-1046. PubMed ID: 28214292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Stokes-Adams attacks in myasthenia gravis: a possible cholinergic side effect.
    Ferguson JH; Turel AP
    Arch Neurol; 1976 Apr; 33(4):308. PubMed ID: 1259650
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects on neuromuscular function of acute chronic exposure to cholinesterase inhibitors in man and in the rat.
    Roberts DV; Taylor K; Wilson A
    J Physiol; 1971 Dec; 219(2):15P. PubMed ID: 4333825
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case report of pyridostigmine induced parkinsonism].
    Iwasaki Y; Kinoshita M; Wakata N
    Rinsho Shinkeigaku; 1988 Jun; 28(6):662-4. PubMed ID: 3233838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.